Article

Utilisation of the Prestwick Chemical Library <sup>®</sup> to identify drugs that inhibit the growth of Mycobacteria

2018-06-28

Abstract excerpt

Tuberculosis (TB) is an infectious bacterial disease that kills approximately 1.3 million people every year. Despite global efforts to reduce both the incidence and mortality associated with TB, the emergence of drug resistant strains has slowed any progress made towards combating the spread of this deadly disease. The current TB drug regimen is inadequate, takes months to complete and poses significant challenges...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 32e82eef-a189-5cf3-919a-6c1aadd1ab7f
DOI: 10.1101/357897

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Utilisation of the Prestwick Chemical Library <sup>®</sup> to identify drugs that inhibit the growth of MycobacteriaDOI 10.1101/357897Read

Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screeningSemantic proximity Read

Identification of the anti-mycobacterial functional properties of piperidinol derivatives.Semantic proximity Read

Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets.Semantic proximity Read

Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosisSemantic proximity Read

Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrBSemantic proximity Read

High-throughput Screening and Sensitized Bacteria Identify an M. tuberculosis Dihydrofolate Reductase Inhibitor with Whole Cell ActivitySemantic proximity Read

Tuberculosis drug discovery in the post‐post‐genomic eraSemantic proximity Read

Target Identification in Anti-Tuberculosis Drug DiscoverySemantic proximity Read

Identification of gene targets that potentiate the action of rifampicin on Mycobacterium bovis BCG.Semantic proximity Read

A high-throughput target-based screening approach for the identification and assessment of Mycobacterium tuberculosis mycothione reductase inhibitorsSemantic proximity Read

Biological Profiling Enables Rapid Mechanistic Classification of Phenotypic Screening Hits and Identification of KatG Activation-Dependent Pyridine Carboxamide Prodrugs With Activity Against Mycobacterium tuberculosis.Semantic proximity Read

State-of-the-art strategies to prioritize Mycobacterium tuberculosis drug targets for drug discovery using a subtractive genomics approachSemantic proximity Read